3Kaunitz AM. Current concepts regarding use of DMPA[J]. J Reprod Med, 2002, 47 (Suppl): 785-789.
4Smith JS, Green J, Berrington E, et aL Cervical cancer and use of hormonal contraceptives: a systematic review [J].Lancet, 2003, 361 (9364) : 1159 -1167.
5Morvno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case - control study [J]. Lancet, 2002, 359 (9312) : 1085 -1092.
6Shumaker SA, Lenault C, Rapp SR, et aL Estrogen plus progestin and the incidence of dementia and mildcegnitive impairment in postmenopausal women: the women, s health initiative memory study: a randomized controlled trial [J].JAMA, 2003, 289 (20): 2651-2662.
7Punlie DM, Bain CJ, Siskind V, et aL Ovulation and risk of epithelial ovarian cancer [J] . lnt J Cancer, 2003, 20 (104) : 228 -232.
8Modan B, Hartge P, Yechezkel G, et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation [J]. N Engl J Med, 2001, 26 (345) : 235 - 240.
9Fernandez E, Vecchia C, Balducci A, et aL Oral contraceptives and colorectal cancer risk : a meta - analysis [J].Br J Cancer, 2001, 84 (5): 722-727.
10Kailas NA, Sifakis S. Koumantakis E. Contracepllon during perimenopause [J]. EurJ Contracept Reprod Heath Care, 2005, 10 (1) : 19 - 25.
